← Back to headlines
Janux Therapeutics GAAP EPS of -$0.51 beats by $0.16
Janux Therapeutics announced its latest financial results, reporting a GAAP EPS of -$0.51, which beat analyst estimates by $0.16.
26 Feb, 22:05 — 26 Feb, 22:05
ℹOnly 1 source covers this story
